5647000: Griseofulvin ultramicrosize (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antifungal\Griseofulvin ultramicrosize
\Substance categorized by disposition\Immunomodulator\Mitotic inhibitor\Microtubule inhibitor\Griseofulvin ultramicrosize

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antifungal\Griseofulvin ultramicrosize

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Benzofuran (substance)\Griseofulvin ultramicrosize

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

10417012 Griseofulvin ultramicrosize en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

794985012 Griseofulvin ultramicrosize (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Griseofulvin ultramicrosize	Is a	Product containing griseofulvin (medicinal product)	false	Inferred relationship	Some
Griseofulvin ultramicrosize	Is a	Griseofulvin (substance)	false	Inferred relationship	Some
Griseofulvin ultramicrosize	Is a	Griseofulvin microsize	false	Inferred relationship	Some
Griseofulvin ultramicrosize	Is a	Antifungal	true	Inferred relationship	Some
Griseofulvin ultramicrosize	Is a	Benzofuran (substance)	true	Inferred relationship	Some
Griseofulvin ultramicrosize	Is a	allergène médicamenteux	false	Inferred relationship	Some
Griseofulvin ultramicrosize	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Griseofulvin (substance)	true	Inferred relationship	Some
Griseofulvin ultramicrosize	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antifungal	true	Inferred relationship	Some
Griseofulvin ultramicrosize	Is a	Microtubule inhibitor	true	Inferred relationship	Some
Griseofulvin ultramicrosize	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Microtubule inhibitor (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Griseofulvin ultramicrosize 250 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Griseofulvin ultramicrosize	Inferred relationship	Some
Griseofulvin ultramicrosize 165 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Griseofulvin ultramicrosize	Inferred relationship	Some
Griseofulvin ultramicrosize 330 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Griseofulvin ultramicrosize	Inferred relationship	Some
Griseofulvin ultramicrosize 125 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Griseofulvin ultramicrosize	Inferred relationship	Some
Griseofulvin ultramicrosize 125 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Griseofulvin ultramicrosize	Inferred relationship	Some	1
Griseofulvin ultramicrosize 125 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Griseofulvin ultramicrosize	Inferred relationship	Some	1
Griseofulvin ultramicrosize 165 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Griseofulvin ultramicrosize	Inferred relationship	Some	1
Griseofulvin ultramicrosize 165 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Griseofulvin ultramicrosize	Inferred relationship	Some	1
Griseofulvin ultramicrosize 330 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Griseofulvin ultramicrosize	Inferred relationship	Some	1
Griseofulvin ultramicrosize 330 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Griseofulvin ultramicrosize	Inferred relationship	Some	1
Griseofulvin ultramicrosize 250 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Griseofulvin ultramicrosize	Inferred relationship	Some	1
Griseofulvin ultramicrosize 250 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Griseofulvin ultramicrosize	Inferred relationship	Some	1
Griseofulvin ultramicrosize 125 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Griseofulvin ultramicrosize	Inferred relationship	Some	1
Griseofulvin ultramicrosize 250 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Griseofulvin ultramicrosize	Inferred relationship	Some	1
Griseofulvin ultramicrosize 165 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Griseofulvin ultramicrosize	Inferred relationship	Some	1
Griseofulvin ultramicrosize 330 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Griseofulvin ultramicrosize	Inferred relationship	Some	1

This concept is not in any reference sets